Marcin Frąckiewicz

LIVEMarkets rolling coverageStarted: April 13, 2026, 12:00 AM EDTUpdated: April 13, 2026, 11:59 PM EDT 3 Overlooked TSX Dividend Stocks Beyond Canadian Banks April 13, 2026, 11:34 PM EDT. Canadian banks often dominate portfolios, but three overlooked TSX dividend stocks offer strong alternatives. Freehold Royalties (TSX:FRU) benefits from a unique royalty business model in oil and gas, generating $299.8 million revenue in 2025 with steady dividends. Plaza Retail REIT (TSX:PLZ.UN) focuses on necessity-based retail properties in smaller markets, boosting funds from operations by 8.8% and maintaining a solid dividend payout. Fairfax Financial (TSX:FFH), an insurance and investment firm, quietly compounds

LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 11:59 PM EDT Orora ASX:ORA Faces Earnings Reset After Saverglass Impact and Middle East Disruptions April 10, 2026, 11:59 PM EDT. Orora (ASX:ORA) shares plunged over 8% in one day following a guidance update that revealed an earnings reset at its Saverglass unit due to Middle East supply chain disruptions and a shutdown at the Ras Al Khaimah glass plant. Despite a sharp short-term loss, Orora's 90-day share price rise exceeds 33%, contrasting a longer-term 10.58% annual total shareholder return decline amid ongoing sector pressures. Trading at A$1.49,

LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 11:59 PM EDT AngloGold Ashanti Shares Rise 192% Over Year, Valuation Near Fair Value April 9, 2026, 11:59 PM EDT. AngloGold Ashanti's stock surged 192% over the past year, closing at $108.55. Its valuation, measured by a Discounted Cash Flow (DCF) analysis, suggests a fair value of $119.76 per share, indicating the share price is about 9.4% below intrinsic value-neither a clear bargain nor overpriced. The company's free cash flow is projected to grow to $3.8 billion by 2029. Price-to-Earnings (P/E) ratios remain a key metric for investors

LIVEMarkets rolling coverageStarted: April 7, 2026, 12:00 AM EDTUpdated: April 7, 2026, 11:58 PM EDT Boston Scientific (BSX) Shares Hit 45% Discount; Undervalued Despite 34.7% YTD Drop April 7, 2026, 11:58 PM EDT. Boston Scientific's (BSX) share price has fallen 34.7% year to date, now trading around $61.86, down 31.8% over the past year. Despite this pullback, a discounted cash flow (DCF) analysis values the stock at approximately $112.50, suggesting a 45% undervaluation. Free cash flow forecasts rise from $3.63 billion to $6.84 billion by 2029, underpinning the bullish DCF outlook. The stock trades at a price-to-earnings (P/E) ratio of

LIVEMarkets rolling coverageStarted: April 6, 2026, 12:00 AM EDTUpdated: April 6, 2026, 11:59 PM EDT Firmus Valuation Nears $7 Billion Following Nvidia's Increased Investment April 6, 2026, 11:52 PM EDT. Artificial intelligence infrastructure start-up Firmus is nearing a $7 billion valuation after Nvidia, the world's largest chipmaker, doubled its stake in Firmus' final private funding round. The company is wrapping up the last phase of a $1 billion-plus pre-IPO capital raise, involving Nvidia and other strategic investors. This financing round precedes Firmus' debut presentation to IPO investors in Asia. The move highlights deepening interest from major tech players ahead of